Tech
In reversal, American Cancer Society urges routine prostate cancer screening
Publication: Ars Technica
Author: Beth Mole
Source published: 12/11/2026, 22:59:51 UTC
Briefing created: 13/11/2026, 14:33:05 UTC
Based on a feed excerpt; full article content has not been acquired. Source evidence retrieved 13/11/2026, 14:28:24 UTC.
Briefings
The American Cancer Society updated its prostate cancer screening guidelines, shifting recommendations for men aged 50 to 69 to routine PSA testing every two years. Men at high risk due to family history or race are advised to start at age 45 and test annually. Coverage is limited to the specific age and risk stratification criteria provided in the source text.
Key points
- Men aged 50 to 69 at average risk should undergo PSA testing every two years.
- Men at high risk due to family history or race should start testing at age 45 and test annually.
Context
The American Cancer Society released new guidelines on Thursday, shifting screening recommendations for men aged 50 to 69 to routine PSA testing every two years. Men at high risk due to family history or race are advised to start at age 45 and test annually.
Limitations
Coverage is limited to the specific age and risk stratification criteria provided in the source text. No data on screening rates, patient outcomes, or geographic disparities is available.
Generated by Bittrees-hosted qwen35-2b sha256:aaf42c8b7c3c on 13/11/2026, 14:33:05 UTC. Based on publisher-provided feed evidence; may not cover the full original article. Check the source for details.
View archived briefing on IPFS
bafybeignp7ulmc3xuai2awvtb6h7535d34efngkzoxsvulhc64ceof4teq